Agenda Sessions

February 22, 2011

5:00 p.m. - Registration Opens

5:00 p.m. - 6:30 p.m.Welcome Reception

The Welcome Reception will be located in the Grande Room

February 23, 2011

7:30 a.m. - 8:00 a.m.Registration and Breakfast

8:00 a.m. - 9:30 a.m.Plenary Breakfast: Corporate Venture Funds-Different Strokes for Different Folks

Moderator:
John Diekman, Founder & Managing Partner, 5AM Ventures

Confirmed Panelists:
BJ Bormann, Head of BD, Boehringer Ingelheim
Barbara Dalton, VP Worldwide Business Development, Venture Capital, Pfizer Venture Investments, Pfizer Inc.
John Dunn, Executive VP, New Ventures, Biogen Idec
Carole Nuechterlein, Head, Roche Venture Fund

8:00 a.m. - 5:00 p.m.Partnering Open 1:1 Meetings

9:30 a.m. - 10:00 a.m.Refreshment Break

10:00 a.m. - 11:30 a.m.Plenary Session: Japanese Pharma Panel

Moderator:
Steve Ryder, President, Astellas Pharma Global Development

Confirmed Panelists:
Andy Hull, VP of Global Alliance Management, Takeda Pharmaceuticals North America, Inc.
George Montgomery, Managing Director, Sagent Advisors, Inc.
Alex Scott, VP of Commercial Development, Eisai Inc.
Jeffrey W. Warmke, Ph.D, SVP, External Scientific Affairs, Daiichi Sankyo Inc.

11:30 a.m. - 12:00 p.m.Networking Break

12:00 p.m. - 1:30 p.m.Plenary Lunch: Pharma Spin Outs, Divestitures and Out Licensing

Moderator:
Mark Edwards, Founder of Recombinant Capital

Confirmed Panelists:
Darren Carroll, VP, Corporate BD, Eli Lilly and Company
Charles Homcy, Venture Partner, Third Rock Ventures
Roger Newton, CEO & Founder, Esperion Therapeutics
Magda Marquet, Co-Chairman & Founder, Althea Technologies
Steven Mento, President, CEO & Co-Founder, Conatus Pharmaceuticals

1:30 p.m. - 2:00 p.m.Refreshment Break

2:00 p.m. - 5:00 p.m.Company Presentations

5:30 p.m. - 6:30 a.m.Gala Reception Transportation

Transportation from the Estancia to the Evans Garage will begin at 5:30 p.m.

6:00 p.m. - 9:00 p.m.Gala Reception: Evans Garage

AN EVENING AT THE EVANS GARAGE IS A STEP BACK IN TIME— A UNIQUE OPPORTUNITY TO VISIT A WORLD-CLASS PRIVATECOLLECTION OF VINTAGE AUTOMOBILES WHILE ENJOYINGGOURMET DINING IN A BEAUTIFUL AND WHIMSICAL SETTING. THE GARAGE IS A PRIVATE, FAMILY-OWNED ELEGANT MUSEUMFEATURING A DRAMATIC COLLECTION OF CLASSIC AND ANTIQUECARS, FURNITURE, AND OTHER PERIOD PIECES; A TIMECAPSULE FILLED WITH MEMORIES OF THE GRAND, GRACIOUS,AND ELEGANT ERAS OF THE PAST. DISPLAYS INCLUDE RARE,BEAUTIFUL ANTIQUES AND AN ECLECTIC COLLECTION OFCONSTANTLY-EVOLVING CONVERSATION PIECES.THE COLLECTION AND PASSION FOR COLLECTING ANTIQUE ANDCLASSIC CARS HAVE BEEN PASSED DOWN THROUGH THEGENERATIONS OF THE EVANS FAMILY.

February 24, 2011

7:30 a.m. - 8:00 a.m.Networking Breakfast

8:00 a.m. - 5:00 p.m.Partnering Open 1:1 Meetings

8:00 a.m. - 9:30 a.m.Plenary Session: Shareholder Activism

Moderator:
Karen Bernstein, Chairman & Editor in Chief, BioCentury

Confirmed Panelists:
Alex Denner, Sr. Managing Director, entities affiliated with Carl C. Ichan
Karin Eastham, Board of Directors for Amylin Pharmaceuticals, Genoptix, Geron Corporation, Illumina and Trius Therapeutics
Faheem Hasnain, President & CEO, Receptos Inc.
Jay Kranzler, Chairman Emeritus, Cypress Biosciences Inc.

9:30 a.m. - 10:00 a.m.Refreshment Break

10:00 a.m. - 12:00 p.m.Company Presentations

12:00 p.m. - 1:30 p.m.Plenary Lunch: Funding the Gap

Moderator:
James Schaeffer, Executive Director, Worldwide Licensing and External Research, Merck Research Labratories

Confirmed Panelists:
Melissa Ashlock, M.D., Vice President of Drug Discovery, Cystic Fibrosis Foundation
Richard Douglas, SVP, Corporate Development, Genzyme Corporation
Paul Laikind, CBO and Senior VP of BD, Sanford Burnham Medical Research Institute
Tony Rosenberg, Head of Global BD & Licensing, Novartis Pharma AG
James Schaeffer, Executive Director, Worldwide Licensing and External Research, Merck

1:30 p.m. - 2:00 p.m.Refreshment Break

2:00 p.m. - 3:00 p.m.Company Presentations

3:00 p.m. - 5:00 p.m.Closing Plenary Session

3:00 p.m. - 3:20 p.m.
Does Big Pharma Want What You Have
Presented by:
Jon McGarity, Executive Vice President, Campbell Alliance

3:20 p.m. - 5:00 p.m.
Case Studies

Moderator:
Stephen Ferruolo, Partner, Goodwin Procter LLP

Confirmed Presenters:
Marty Birkhofer, VP Strategic Transactions, Bristol Myers Squibb
Jeff Southerton, Executive Director, Worldwide Business Development, Pfizer Inc.
Barbara Yanni, VP and Chief Licensing Officer, Merck & Co.
Dan Zabrowski, Global Head, Roche Partnering

5:00 p.m. - 6:00 p.m.Closing Reception